1. Home
  2. BBCP vs CCCC Comparison

BBCP vs CCCC Comparison

Compare BBCP & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Concrete Pumping Holdings Inc.

BBCP

Concrete Pumping Holdings Inc.

HOLD

Current Price

$10.53

Market Cap

367.7M

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.70

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BBCP
CCCC
Founded
1983
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
367.7M
404.7M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
BBCP
CCCC
Price
$10.53
$3.70
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$8.25
$12.20
AVG Volume (30 Days)
289.5K
4.0M
Earning Date
06-04-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
$392,867,000.00
$35,947,000.00
Revenue This Year
$4.90
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$5.56
$1.69
52 Week High
$12.19
$5.17

Technical Indicators

Market Signals
Indicator
BBCP
CCCC
Relative Strength Index (RSI) 49.10 43.11
Support Level $10.39 $2.10
Resistance Level $12.08 $3.89
Average True Range (ATR) 0.49 0.37
MACD -0.21 -0.10
Stochastic Oscillator 7.78 16.47

Price Performance

Historical Comparison
BBCP
CCCC

About BBCP Concrete Pumping Holdings Inc.

Concrete Pumping Holdings Inc is a provider of concrete pumping services and concrete waste management services in the fragmented United States and United Kingdom markets. Its large fleet of specialized pumping equipment and trained operators enables it to deliver concrete placement solutions. The company's operating segments include U.S. Concrete Pumping, U.K. Operations, and U.S. Concrete Waste Management Services, with the majority of revenue generated from the U.S. Concrete Pumping segment. Geographically, it operates in the United States and the United Kingdom, generating majority of its revenue from the United States.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: